Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Avastin
Bevacizumab 25mg/mL
Concentrate for infusion
Roche Products (NZ) Limited
Genentech Inc, California, United States of America
F Hoffmann-La Roche Limited, Basel, Switzerland
Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Ozurdex
Dexamethasone 700mcg
Intraocular implant
Allergan New Zealand Limited
Allergan Pharmaceuticals Ireland, County Mayo, Ireland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Robinul
Glycopyrronium bromide 0.2mg/mL
Solution for injection
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Hameln Pharmaceuticals GmbH, Hameln, Germany
Biologici Italia Laboratories Srl, Milan, Italy
|
Dated this 9th day of April 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz